The antioxidant role of paraoxonase 1 and vitamin e in three autoimmune diseases

Skin Pharmacology and Physiology

Volumn 26, Issue 1, 2013, Pages 2-7

  Ramadan, R ^a   Tawdy, A ^a   Abdel Hay, R ^a   Rashed, L ^a   Tawfik, D ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Port Said University   (Egypt)

Author keywords

Alopecia areata; Paraoxonase; Psoriasis; Vitamin E; Vitiligo

Indexed keywords

ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE 1;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; TISSUE LEVEL; VITAMIN BLOOD LEVEL; VITILIGO;

EID: 85027955109     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000342124     Document Type: Article

References (15)

1. Kavanagh GM, Burton JL, Donnell VO: Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. Br J Dermatol 1996; 134: 234-237. (Pubitemid 26053577)
2. Abdel Fattah NS, Ebrahim AA, El Okda ES: Lipid peroxidation/antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol 2011; 25: 403-408.
3. Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F: Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009; 27: 176-180.
4. Shaker ME, Houssen ME, Abo-Hashem EM, Ibrahim TM: Comparison of vitamin E, Lcarnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress. J Physiol Biochem 2009; 65: 225-233.
5. Wang G, Cai P, Ansari GA, Khan MF: Oxidative and nitrosative stress in trichloroethene- mediated autoimmune response. Toxicology 2007; 229: 186-193. (Pubitemid 44937488)
6. Popov I, Lewin G: A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 1991; 35: 229-236.
7. Passi S, Grandinetti M, Maggio F, Stancato A, De Luca: Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-85. (Pubitemid 128532953)
8. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40. (Pubitemid 43227479)
9. Fredriksson T, Pettersson U: Severe psoria - sis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244. (Pubitemid 8387357)
10. Marks R, Barton SP, Shuttleworth D, Finlay AY: Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235-240. (Pubitemid 19070211)
11. Njoo MD, Das PK, Bos JD, Westerhof W: Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 1999; 135: 407-413. (Pubitemid 29172092)
12. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K: Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999; 40: 242-246. (Pubitemid 29072802)
13. Sreekantha, Manjunatha Goud BK, Avinash SS, Amareshwara M, Sudhkar, Vinodchandran: Antioxidant vitamins, calcium and phosphorus levels in psoriasis. Int J Pharma Bio Sci 2010; 4:B208-B211. 14 Naziroglu M, Kokcam I: Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 2000; 18: 169-173.
14. Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F: Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994; 7: 110-115.
15. Mahgoub D, El-Eishi N, Rashed L: Estimation of paraoxonase-1 and superoxide dismutase in vitiligo patients before and after photochemotherapy. J Egypt Wom Dermatol Soc 2012; 9: 52-56.